HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ponari, O. Articles by Poti, R. Search for Related Content PubMed PubMed Citation Articles by Ponari, O. Articles by Poti, R.

The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 87-94, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Predictive value of preoperative in vitro and in vivo studies for correct individual heparinization in cardiac surgery

O Ponari, M Corsi, C Manotti, M Pini, D Portioli and R Poti

Heparin administration for operations with extracorporeal circulation (ECC) usually is performed following prefixed, standardized protocols. These regimens secure an adequate level of anticoagulation, but they often involve prolonged periods of overheparinization associated with an undue risk of hemorrhage. The predictive value of preoperative studies in the anticoagulant effect of heparin was investigated in 10 patients. The study was performed both in vitro and in vivo using the Xa inhibitor assay as an index of the anticoagulation induced by heparin. Adding variable amounts of heparin in vitro to patient's plasma resulted in straight (at least up to 7 U. per milliliter) and parallel, but not coincident, dose/response curves, so confirming a different individual sensitivity to heparin. Disappearance curves of the anticoagulant effect in plasma following intravenous administration of a single standard dose of heparin in the same patients showed an even greater patient-to-patient variability, with "half-life" times ranging from 30 to 150 minutes. No relationship was found between the parameters (in vitro sensitivity to heparin and clearance rate from plasma in vivo). Moreover, neither of them could be correlated with the response to heparin, subsequently observed during ECC in the same patients. Preoperative investigations with the methods presently available are not adequate to choose individual heparin administration regimens for cardiac operations.

This article has been cited by other articles:

				J. A. Dearani, T. C. Axford, M. A. Patel, N. A. Healey, P. T. Lavin, and S. F. Khuri Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2235 - 2243. [Abstract] [Full Text] [PDF]

				A. S. Weisinger and J. H. Levy Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 259 - 271. [Abstract] [PDF]

				G. Singh, M. Gayler, R. Wyatt, and T. Spyt Clinical significance of heparin in the residual pump oxygenator blood, reinfused postoperatively after cardiopulmonary bypass Perfusion, July 1, 1994; 9(4): 271 - 275. [Abstract] [PDF]

				J. R. Handy, F. G. Spinale, R. Mukherjee, and F. A. Crawford Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1050 - 1058. [Abstract] [Full Text]

				G. D. Buckberg Normothermic blood cardioplegiaAlternative or adjunct? J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 860 - 867. [Abstract] [Full Text]

				C. Aren Review article : Heparin and protamine during cardiac surgery Perfusion, July 1, 1989; 4(3): 171 - 181. [PDF]